# Guanfacine Clinical Trial for Smoking Cessation

> **NCT02051309** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 121 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Guanfacine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02051309
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2020-11
- **Final completion:** 2020-11
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051309, "Guanfacine Clinical Trial for Smoking Cessation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02051309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*